Go Search
Do More to Stay Healthy: View tips for healthy living past menopause

EVISTA is indicated for the treatment of osteoporosis in women past menopause.

Because osteoporosis is more common after menopause, now is an important time to take steps to reduce the risk of spine fracture. When you talk to your doctor, this information can help guide the discussion about ways you can reduce your risk of spine fracture.

About Osteoporosis
As women age, they are more susceptible to spine fracture due to decreased bone mass. Bone mass begins to decline at a steady rate until after menopause, when the rate of bone loss may increase significantly. Once bone loss reaches a certain point, low bone mass becomes osteoporosis.

Osteoporosis Risk
The risk factors for osteoporosis include:

Normal Bone / Osteoporotic Bone
  • Family history of osteoporosis
  • Female of advancing age
  • Cigarette smoking
  • Excessive use of alcohol
  • Sedentary lifestyle
  • Low calcium diet
  • Caucasian or Asian descent
  • Slender body build
  • Early menopause

Women with osteoporosis are more likely to experience a spine fracture than women without osteoporosis. And once they experience a spine fracture, the risk of experiencing another spine fracture increases.

Bone Turn-Over Rate
Bone undergoes a continuous cycle of resorption and formation. Old bone is routinely "resorbed," or carried away, by your body as part of its normal function. At the same time, new bone is formed in your skeleton. The rate of old bone resorption and new bone formation changes over time. As you go through your childhood and teen years, new bone is added faster than old bone is resorbed, resulting in overall bone growth. Most women acquire a majority of their bone mass by age 18, which peaks by age 30. This is when your bones are the most dense and strong.

1 out of every 2 women will break a bone due to osteoporosis in her lifetime.

After age 30, the process very slowly reverses, meaning that more bone is carried away than is formed. This results in overall bone loss, which can continue as you age. When bone resorption happens too quickly, or new bone grows too slowly, a person may reach the point of developing osteoporosis. The disease is more likely to develop if you did not acquire the best bone mass during your bone-building years.

Note: EVISTA is only indicated for women past menopause.

Stages of Bone Loss

  • Decreased Estrogen Causes Bone Loss: Since the hormone estrogen helps protect against bone loss, less estrogen in your body results in more bone loss. That's why the years after menopause—when a woman's ovaries stop producing estrogen—is the time of life when bone loss is most rapid. In fact, women can lose up to 20% of their bone mass in the 5 to 7 years following menopause.
  • Low Bone Mass May Become Osteoporosis: When you reach a point where you have significantly less bone than normal, you have a condition called low bone mass. With further bone loss, your bones may no longer have a normal structure. At this point you would have osteoporosis.
  • Osteoporotic Bones Can Break Easily: Osteoporotic bones are thin and fragile, and can break easily. Once you experience one spine fracture, the risk of experiencing another spine fracture increases significantly.
Ready to treat your osteoporosis? Learn how EVISTA can help
Next: Help Reduce Both Risks with EVISTA

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the treatment of osteoporosis and for the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis.

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the treatment and prevention of osteoporosis in postmenopausal women.

Indication for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for the reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer.

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Indications for EVISTA® (raloxifene HCI tablets)
EVISTA is indicated for:

  • The treatment and prevention of osteoporosis in postmenopausal women
  • The reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis
  • The reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer

If you already have or have had breast cancer, EVISTA does not treat it or prevent its return, and it does not reduce the risk of all forms of breast cancer.

Important Safety Information About EVISTA

You should not take EVISTA if you have had or are at risk for getting blood clots in the legs, lungs or eyes, as it may increase the risk of blood clots. Stop taking EVISTA and call your doctor if you have leg pain or warmth, swelling of the legs, hands or feet, chest pain, shortness of breath or a sudden vision change, as these may be signs of a blood clot. Being unable to move around for long periods may increase this risk. If you will need to be still for a long time, talk to your doctor about ways to reduce the risk of blood clots.

EVISTA does not increase the risk of a heart attack or stroke in women who have had or are at risk for a heart attack; however; EVISTA increases the likelihood of dying from stroke in these women, should one occur. Before taking EVISTA tell your doctor if you have had a stroke, a mini-stroke, irregular heartbeat, high blood pressure, heart attack, history of smoking, or believe you have other risk factors for stroke or a heart attack.

Before Taking EVISTA

EVISTA is not right for everyone. You should only take prescription EVISTA if you are past menopause. Before taking EVISTA, talk to your doctor about all your medical conditions. If you are pregnant, nursing or may become pregnant, do not take EVISTA, as it may cause fetal harm. Women with liver or kidney disease should use EVISTA with caution. EVISTA should not be taken with estrogens in the form of pills, patches or injections.

Side Effects

Side effects may include hot flashes, leg cramps, swelling, flu-like symptoms, joint pain, and sweating. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For more safety information, please see the Medication Guide and full Prescribing Information.